INDICATION

Aptensio XR® (methylphenidate HCl extended-release) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

For US Healthcare Professionals

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCE

CNS stimulants, including Aptensio XR, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.

.

ADMINISTRATION

Administration considerations

.
  • Aptensio XR® (methylphenidate HCl extended‐release) should be taken exactly as prescribed, at the same time each day1
  • Aptensio XR may be taken with or without food1
  • Aptensio XR may be taken whole, or the capsule may be opened and the entire contents sprinkled onto applesauce1
    • The entire contents of the capsule should be consumed immediately, and the beads should not be chewed1
    • The dose of a single capsule should not be divided. The contents of the entire capsule should be taken, and patients should not take anything less than 1 capsule per day1
Dose Dose
.

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCE

CNS stimulants, including Aptensio XR, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.